D. E. Shaw & Co., Inc. Fulgent Genetics, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $100 Billion
- Q1 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 440,016 shares of FLGT stock, worth $8.88 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
440,016
Previous 130,684
236.7%
Holding current value
$8.88 Million
Previous $2.41 Million
208.16%
% of portfolio
0.01%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding FLGT
# of Institutions
197Shares Held
18.2MCall Options Held
379KPut Options Held
52.9K-
Black Rock Inc. New York, NY3.92MShares$79.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.97MShares$39.8 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$23.6 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.03MShares$20.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA806KShares$16.3 Million0.04% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $611M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...